Can Public Policy Control Rising Drug Prices?
|
|
- Alison Short
- 5 years ago
- Views:
Transcription
1 Can Public Policy Control Rising Drug Prices? Vivian Ho, PhD James A. Baker III Institute Chair in Health Economics Director, Center for Health and Biosciences Professor, Department of Economics at Rice University Professor, Department of Medicine at Baylor College of Medicine The Houston Economics Club November 7, 2018 #BakerHealth
2 What is the problem? Outline Policy Options Legislation Expert Recommendations Trump Administration
3 Billions $4,000 $3,500 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $ National Health Expenditures Total Expenditures Percent Growth * 2018* 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% Percent Change from Previous Year * projected
4 Average Annual Percent Change from Previous Year National Health Expenditures Hospital Care Physician and Clinical Services Prescription Drugs Epipen $264 Epipen $349 Daraprim $750 Epipen $461 Epipen $608 * projected
5 Medicare Trustees Estimates for 17-27: Average Annual Growth in Medicare Beneficiary Costs for Part A, Part B, and Part D Between 2017 and Part A Part B Part D Per beneficiary spending: 2017 $5,160 $5,915 $2, $7,443 $10,004 $3,296 Source: 2018 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplemental Medical Insurance Trust Funds
6 National Health Expenditures Hospital Care Physician and Clinical Services Prescription Drugs Percent Distribution
7 Old drug price inflation - Valeant Pharmaceuticals
8 Average Annual Prescription Drug Price Change vs. Inflation Source: Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: , AARP Public Policy Institute 2017.
9 Annual Percentage Change in Retail Prices by Drug Type, Source: Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: , AARP Public Policy Institute 2017.
10 Commonly Prescribed Drugs for Seniors The top 20 most commonly prescribed brand-name drugs for seniors in Medicare Part D in 2015 were: Advair Diskus Nexium Restasis Ventolin HFA Crestor Nitrostat Spiriva Handihaler Voltaren Gel Januvia Novolog Symbicort Xarelto Lantus/Lantus Solostar Premarin Synthroid Zetia Lyrica Proair HFA Tamiflu Zostavax Source: US Senate Homeland Security and Government Affairs Committee, Minority Office, March 2016
11 Popular Drug Price Change vs. Inflation Source: US Senate Homeland Security and Government Affairs Committee, Minority Office, March 2016
12 Total U.S. Prescriptions of Most Commonly Prescribed Brand-Name Drugs Product 2012 Prescriptions 2017 Prescriptions Prescription Difference Percent Change (U.S. Total) (U.S. Total) ( ) ( ) Ventolin HFA 17,414,376 27,069,765 9,655,389 55% Proair HFA 24,873,170 25,977,546 1,104,376 4% Synthroid 23,073,988 18,411,640-4,662,348-20% Lantus/Lantus Solostar 18,558,937 17,004,123-1,554,814-8% Advair Diskus 17,018,219 10,700,788-6,317,431-37% Lyrica 9,114,028 10,373,276 1,259,248 14% Januvia 8,893,922 9,913,198 1,019,276 11% Symbicort 5,246,325 9,888,532 4,642,207 88% Xarelto 1,078,207 9,593,823 8,515, % Spiriva Handihaler 9,625,240 5,759,976-3,865,264-40% Novolog 3,385,303 5,045,237 1,659,934 49% Restasis 2,818,474 3,037, ,797 8% Nexium 22,021,459 2,246,968-19,774,491-90% Tamiflu 3,313,707 2,143,796-1,172,911-35% Premarin 5,223,690 2,046,125-3,177,565-61% Voltaren Gel 2,954,278 1,964, ,613-33% Zetia 7,915,532 1,730,633-6,184,899-78% Crestor 25,337,566 1,604,070-23,733,496-94% Zostavax 2,291,538 1,344, ,921-41% Nitrostat 4,273, ,442-3,963,971-93% Total 214,434, ,165,491-48,268,881-33%
13 Price Prescription Drug Demand P 2017 P 2012 D Q 2017 Q 2012 Quantity
14 Prices Matter
15 15 Historical prices for one week of treatment with Enbrel and Gleevec
16 Declining value Prices of Gleevec vs. iphone over time $3,000 $2,500 Cost ($) $2,000 $1,500 $1,000 $500 Price of iphone/ghz with contract AWP of 1 week treatment of 400mg Gleevec $ Year
17 Value (benefits in relation to costs) declining
18 Why we should care patient access Access Spending
19
20
21 Policy Drug Policy Legislation Introduced since 2015 Allow Importation / Re importation Boost Generic Competition Reduce Branded Monopolies Ban/Restrict DTC Advertising Require Price & Cost Transparency Use Value-based payment Apply Price Inflation Limiters Let Government be the Purchaser Legislate Access to Treatment Require Rebates to Mcare/caid Legislators McCain (R-AZ), Franken (D-MN), Klobuchar (D-MN), Sanders (I-VT), Ellison (D-MN) Cruz (R-TX), Smith (D-WA), Stivers (R-OH), Brown (D-OH), Franken (D-MN), Klobuchar (D-MN), Shrander (D-OR), Sanders (I-VT), Vitter (R-LA), Leahy (D-VT), Collins (R-ME), McKinley (R-WV), Goodlatte (R- VA) Wyden (D-OR), Franken (D-MN), Sanders (I-VT), Lance (R-NJ), Ryan (R-WI) DeLauro (D-CT), Franken (D-MN) Franken (D-MN), Wyden (D-OR), Sanders (I-VT), Baldwin (D-WI), Durbin (D-IL), Perlmutter (D-CO), Collins (R-GA) Ryan (R-WI), President Donald Trump Franken (D-MN), Wyden (D-OR), Brown (D-OH), DeLauro (D-CT) Sanders (I-VT), Baldwin (D-WI), Franken (D-MN), Klobuchar (D-MN) Sanders (I-VT) Sanders (I-VT)
22 Released: November 30, 2017
23 NASEM Rec A: Boost Generic Competition Pass legislation to eliminate pay-for-delay practice. Stop brand-name drugs from unfairly restricting access to samples that generic makers need to formulate competing drugs.
24
25 May 17, November 8,
26 Requested Listed Drug Inquiries Drug Company # Inquiries Absorica (isotretinoin) Ranbaxy 5 Exjade (deferasirox) Novartis 6 Letairis (ambrisentan) Giliad 10 Revlimid (lenalidomide) Celgene 13 Source: s/abbreviatednewdrugapplicationandagenerics/ucm htm
27 NASEM Rec B: Let Government be the Purchaser Because prices tend to be lower when the purchaser has bargaining power that is at least comparable to that of the seller, the United States could achieve lower prices for prescription drugs by consolidating bargaining power The law bars the govt. from negotiating drug prices for Medicare Part D. Other countries are able achieve lower prices through regulations and negotiation. But U.S. policy makers were lobbied heavily by drug companies.
28
29 NASEM Rec C: Require Greater Price and Cost Transparency Source: National Academies of Sciences, Engineering, and Medicine Making medicines affordable: A national imperative.
30 Source: National Academies of Sciences, Engineering, and Medicine Making medicines affordable: A national imperative.
31 Source: National Academies of Sciences, Engineering, and Medicine Making medicines affordable: A national imperative.
32 Source: National Academies of Sciences, Engineering, and Medicine Making medicines affordable: A national imperative.
33 Source: National Academies of Sciences, Engineering, and Medicine Making medicines affordable: A national imperative.
34 Source: Kaiser Health News, May 30, 2018
35 Frequency and Mean Overpayment Among Pharmacy Claims with Patient Co-pay, 2013 Drugs No. of Claims Frequency of Claims % with overpayment Mean All 9,539, Generic 7,295, Brand 2,244, Source: Van Nuys K. et al, JAMA 2018.
36 NASEM Rec G: Modify the 1983 Orphan Drug Act Cures for rare diseases those affecting less than 200,000 persons in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United States a drug for such disease or condition will be recovered from the sale in the United States. Health Promotion and Disease Prevention Amendments of 1984, Public Law , 98 Stat 2815 (1984), 4.
37 Benefits to Orphan Drug Makers 7 add l years of patent protection. Expedited regulatory review process. Including fewer patients required for clinical trials. Tax credits to help support drug testing. Orphan drugs have higher prices.
38 Problems with Orphan Drug Act Orphan drug status granted for a subset of possible patients, then use is marketed to a larger population. Rituximab granted orphan drug status to treat lymphoma Now used for non-hodgkin s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and several skin disorders. Orphan drugs that have reached blockbuster status (>$1b in sales) Vioxx, Cialis, Botox Some drugs received multiple orphan designations. Gleevec has had 9, w/ $3.3b in sales for 2016.
39 Top lobbying industries in the U.S Top lobbying industries in the United States in 2017, by total lobbying spending (in million U.S. dollars) Spending in million U.S. dollars Pharmaceuticals/Health Products Insurance Electronics Mfg & Equip Business Associations Oil & Gas Electric Utilities Real Estate Hospitals/Nursing Homes Securities & Investment Health Professionals Misc Manufacturing & Distributing Air Transport Telecom Services Health Services/HMOs Education Note: United States; 2017 Further information regarding this statistic can be found on page 8. Source: opensecrets.org; CRP ID
40
41 4 Challenges High list prices for drugs Seniors and government programs overpaying for drugs due to lack of the latest negotiation tools High and rising out-of-pocket costs for consumers Foreign governments free-riding off of American investment in innovation
42 4 Key Strategies Improved competition Better negotiation Incentives for lower list prices Lowering out-of-pocket costs
43 Examples Stop brand name drugs from restricting access to samples needed by generic drug makers. Experiment with value-based purchasing in federal programs. Require manufacturers to include list prices in advertising. Prohibit gag clauses from insurer-pharmacist contracts.
44
45
46 rumps-dramatic-new-proposal-to-lower-medicare-drugprices-by-linking-to-an-international-index/#25d27c554c3a
47 Concluding Remarks Rising drug prices are a threat to the affordability of health care and health insurance. Multiple policy options exist for restraining cost growth. Many options unlikely to discourage innovation. Lobbying by drug companies is preventing forceful policy action.
48 Can Public Policy Control Rising Drug Prices? Thank you! For a copy of the presentation bakerchb@rice.edu
Presentation Outline
2016 Elections November 10, 2016 Grant Couch, Director, Government Relations Christina Lavoie, JD, Assistant Director, Public Policy and Operations Jamie Miller, MBA, Director, Government Relations Presentation
More informationHistorically, state PM&R societies have operated as independent organizations that advocate on legislative and regulatory proposals.
PROMOTING STATE PM&R ADVOCACY NEXT STEPS Historically, state PM&R societies have operated as independent organizations that advocate on legislative and regulatory proposals. PROMOTING STATE PM&R ADVOCACY
More informationSenators to Trump Administration: cutting off funding for public transit project threatens jobs & stifles economy
Senators to Trump Administration: cutting off funding for public transit project threatens jobs & stifles economy May 22 2017 1:18 PM WASHINGTON U.S. Senate Democratic Whip Dick Durbin (D-IL), Senate Democratic
More informationUNTANGLING THE KNOTS What s Possible for Health Reform Efforts
UNTANGLING THE KNOTS What s Possible for Health Reform Efforts Post-Election ACA Update January 30, 2017 Kathryn Bakich Senior Vice President, National Director Health Care Compliance NCPERS 2017 Legislative
More informationNRCAT Action Fund Senate Scorecard
NRCAT Action Fund Senate card The following scorecard is based on records of Senators actions on major pieces of torture related legislation in votes between 2011 and 2018. = Acted against torture = Failed
More informationEnergy Efficiency Bills in the Senate
Energy Efficiency Bills in the Senate There have been a significant number of energy efficiency bills introduced in the Senate during the first few months of the 114 th Congress. A large portion of these
More informationNRCAT Action Fund Senate Scorecard
The following scorecard is based on records of Senators actions on major pieces of torture related legislation in the 109th, 110th, 111th and 112th Congresses (2005 2012). = Acted against torture = Failed
More informationWashington, D.C. Update
Washington, D.C. Update 2016 AMGA CMO Council March 9, 2016 Chester Speed, J.D., LL.M, Vice-President, Public Policy Presentation Outline AMGA Priority Issues Risk Survey Legislative Agenda Elections 1
More informationFederal Health Policy & Politics Report. 114 th Congress 2015 Review/2016 Predictions
Federal Health Policy & Politics Report 114 th Congress 2015 Review/2016 Predictions 30 Years of Combined Experience working with the health care provider industry in Washington Kyle Mulroy kmulroy@wscdc.com
More informationMandated Use of Prescription Drug Monitoring Programs (PMPs) Map
Mandated Use of Prescription Drug Monitoring Programs (PMPs) Map Research Current as of January 2, 2018. This project was supported by Grant No. G1799ONDCP03A, awarded by the Office of National Drug Control
More informationLEGISLATIVE UPDATE FOR ONCOLOGY PHARMACISTS
LEGISLATIVE UPDATE FOR ONCOLOGY PHARMACISTS Ryan N. Bookout, PharmD, BCOP, BCPS Pharmacy Supervisor- Blood and Marrow Transplantation & Cellular Immunotherapy Moffitt Cancer Center August 2018 Objectives
More informationPrivacy Legislation in the 115 th Congress
Privacy Legislation in the 115 th Congress Privacy issues have been extremely active in recent years. In past Congresses, numerous privacy bills have been introduced on a bipartisan basis. In the Senate,
More informationTrends in Medicaid and CHIP Eligibility Over Time
REPORT Trends in Medicaid and CHIP Eligibility Over Time August 2015 Prepared by: Samantha Artiga and Elizabeth Cornachione Kaiser Family Foundation Executive Summary... 1 Section 1: Eligibility Trends
More informationSenate 2018 races. Cook Political Report ratings. Updated October 4, Producer Presentation Center
Senate 2018 races Cook Political Report ratings Updated October 4, 2018 Producer Presentation Center 1 Control of the Senate will depend on the nine Toss Up seats Cook Political Report ratings ALL 2018
More information2/11/2019. National Policy Overview. Disclosures & Objectives. Professional Disclosure. AANP wants NPs to succeed!
National Policy Overview James L. Dickens DNP, RN, FNP BC, FAANP AANP Region 6 Director Disclosures & Objectives No industry conflicts to report. AANP wants NPs to succeed! Objectives: 1. Review recent
More informationHealth Reform 2.0. The Issues, People, and Events That Will Define Regulatory Reforms. Repeal. Replace. The issues. Top Issues for 2017
The Issues, People, and Events That Will Define 2017 The issues Health Care Reform 2.0 Health Care Costs Transformation & Risk Consolidation Population and Community Health Social Determinants of Health
More informationValue for Money: How Important Is Lobbying to Industry?
WWW.IBISWORLD.COM January 2014 1 October 2014 Follow on head on Master page A : How Important Is Lobbying to Industry? By Will McKitterick, Maksim Soshkin and Lucas Isakowitz The amount that industries
More informationOverview of the 116th Congress and Health Policy Landscape
Overview of the 116th Congress and Health Policy Landscape Avalere Health An Inovalon Company November 30, 2018 Copyright 2018. Avalere Health LLC. All Rights Reserved. Table of Contents 1 Voter Sentiments
More informationBylaws of the Prescription Monitoring Information exchange Working Group
Bylaws of the Prescription Monitoring Information exchange Working Group ` Table of Contents Table of Contents... 2 Article I. Introduction... 6 Article II. Purpose... 6 Article III. Membership... 6 Article
More informationElection 2014: The Midterm Results, the ACA and You
Election 2014: The Midterm Results, the ACA and You James Slotnick, JD Sun Life Financial AVP, Broker Education Join the conversation on Twitter using #SLFElection2014 The Midterm Results The Outlook for
More informationGENERIC EQUIVALENT DRUG LAW Act of Nov. 24, 1976, P.L. 1163, No. 259 AN ACT Relating to the prescribing and dispensing of generic equivalent drugs.
GENERIC EQUIVALENT DRUG LAW Act of Nov. 24, 1976, P.L. 1163, No. 259 AN ACT Cl. 35 Relating to the prescribing and dispensing of generic equivalent drugs. The General Assembly of the Commonwealth of Pennsylvania
More informationRULE 1.1: COMPETENCE. As of January 23, American Bar Association CPR Policy Implementation Committee
American Bar Association CPR Policy Implementation Committee Variations of the ABA Model Rules of Professional Conduct RULE 1.1: COMPETENCE A lawyer shall provide competent representation to a client.
More informationConstitution in a Nutshell NAME. Per
Constitution in a Nutshell NAME Per Preamble We the People of the United States, in Order to form a more perfect Union, establish Justice, insure domestic Tranquility, provide for the common defense, promote
More informationHealth Reform Law - Advisory Panels, Boards, Commissions, & Stakeholder Involvement
Reporting Requirements 1001 adding 2717 of the PHSA Health Information Transactions 1104(g) State Exchange Operations 1321(a)(2) CO-OP Advisory Board -experts in health care quality and relevant stakeholders
More informationNew Ambassador Orientation. Laura Keivel Manager, Grassroots Advocacy
New Ambassador Orientation Laura Keivel Manager, Grassroots Advocacy Arthritis Foundation Advocacy Advocacy and Access is part of the National Office based in Washington, DC New state advocacy initiatives
More informationThe Aftermath of the Elections ABC Virginia Webinar
The Aftermath of the Elections ABC Virginia Webinar November 10, 2016 Get Into Politics or Get Out of Business Overview U.S. House, Senate and White House Results State Results: GOP Domination Continues
More informationTHE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003
THE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003 A Legislative History of P.L. 108-173 by Mike Welsh William S. Hein & Co., Inc Buffalo, New York 2007 ISBN 978-0-8377-1409-7 Introduction,
More informationFederal Update NCSL Standing Committee on Health & Human Services. Joy Johnson Wilson NCSL Washington Office
Federal Update NCSL Standing Committee on Health & Human Services Joy Johnson Wilson NCSL Washington Office KEY ENACTMENTS Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2; P.L. 114-10) The
More information6/11/2014. Effective Grassroots Involvement in the Policymaking Process LEARNING OBJECTIVES:
Effective Grassroots Involvement in the Policymaking Process DISCLOSURE INFORMATION: 2014 Tennessee Pharmacists Association Annual Convention Heidi Ann Ecker Heidi Ann Ecker NACDS Director of Government
More informationPolarization: Implications for Policymaking & Accountability
Polarization: Implications for Policymaking & Accountability Carlos Algara calgara@ucdavis.edu July 26, 2017 Agenda 1 Wrapping up the Pivotal Politics Model 2 Procedural Cartel (Partisan) Model 3 Polarization
More informationDebt Ceiling Legislation: The Budget Control Act of 2011
Debt Ceiling Legislation: The Budget Control Act of 2011 September 16, 2011 Enacted on August 2 as Public Law 112-25, the Budget Control Act of 2011 (the BCA or the Act), also referred to as the debt ceiling
More information45 STATES AND THE DISTRICT OF COLUMBIA PERMIT DIRECT PETITIONS TO A COURT FOR TREATMENT FOR A PERSON WITH A SEVERE MENTAL ILLNESS
45 STATES AND THE DISTRICT OF COLUMBIA PERMIT DIRECT PETITIONS TO A COURT FOR TREATMENT FOR A PERSON WITH A SEVERE MENTAL ILLNESS State Can adults directly petition the court for treatment? Statutory Language
More informationOctober 3, United States Senate Washington, DC Dear Senator:
October 3, 2010 United States Senate Washington, DC 20510 Dear Senator: Congratulations and thank you on behalf of the National Association of Manufacturers (NAM), the nationʼs largest industrial trade
More informationSupreme Court Decision What s Next
Supreme Court Decision What s Next June 3, 2015 Provided by Avalere Disclaimer Organizations may not re use material presented at this AMCP webinar for commercial purposes without the written consent of
More informationNew Federal Initiatives Project
New Federal Initiatives Project Health Care Reform: Implications for the Intellectual Property Community By David Applegate and Arthur Gollwitzer III* May 5, 2010 The Federalist Society for Law and Public
More information2015: Policy & Advocacy Year in Review
2015: Policy & Advocacy Year in Review Shawn Gremminger, MPP, Director, Legislative Affairs Erin O Malley, Director, Policy December 17, 2015 AGENDA Capitol Hill 2015 Policy 2015 Current Issues and 2016
More informationAGENTS OF CHANGE OR MORE OF THE SAME?
The National Association of Business Political Action Committees 2016 Biennial Post Election Conference AGENTS OF CHANGE OR MORE OF THE SAME? Paul Brathwaite & John Feehery November 17, 2016 House and
More informationRULE 3.1: MERITORIOUS CLAIMS AND CONTENTIONS
American Bar Association CPR Policy Implementation Committee Variations of the ABA Model Rules of Professional Conduct RULE 3.1: MERITORIOUS CLAIMS AND CONTENTIONS A lawyer shall not bring or defend a
More informationCampaign 16. A Hawthorn Group visit with Kansas City Chamber June 24, 2016
Campaign 16 A Hawthorn Group visit with Kansas City Chamber June 24, 2016 Agenda I. The Knowns II. The Unknowns III. The Early Appeals IV. The Hard Questions Bring Down Title The Knowns It s a Big Political
More informationRULE 1.14: CLIENT WITH DIMINISHED CAPACITY
American Bar Association CPR Policy Implementation Committee Variations of the ABA Model Rules of Professional Conduct RULE 1.14: CLIENT WITH DIMINISHED CAPACITY (a) When a client's capacity to make adequately
More informationSecond medical use or indication claims. [Please insert name last name in CAPITAL letters please]
Question Q238 National Group: Title: Contributors: Reporter within Working Committee: New Zealand Second medical use or indication claims Michael BROWN, Partner Helen BELLCHAMBERS, Associate A J Park [Please
More information2017 Federal Budget Budget
2017 Federal Budget 2017 Budget By law, President s Budget must be submitted by first Monday of February (Feb. 6.) Past three outgoing administrations submitted transition budgets to Congress to help with
More informationA POST-ELECTION VIEW FROM WASHINGTON: IMPACT OF THE 2016 PRESIDENTIAL AND CONGRESSIONAL CONTESTS
2015 Morgan, 2016 Morgan, Lewis Lewis & Bockius & Bockius LLP LLP A POST-ELECTION VIEW FROM WASHINGTON: IMPACT OF THE 2016 PRESIDENTIAL AND CONGRESSIONAL CONTESTS Matthew Miner, Partner, Washington D.C.
More informationPresentation to the Bakery, Confectionery, Tobacco Workers and Grain Millers' International Union. Paul Lemmon July 26, 2010
Presentation to the Bakery, Confectionery, Tobacco Workers and Grain Millers' International Union Paul Lemmon July 26, 2010 Our Hard Work in 2006 Our Hard Work in 2008 Who We re Fighting Speaker Boehner?
More informationPrison Price Tag The High Cost of Wisconsin s Corrections Policies
Prison Price Tag The High Cost of Wisconsin s Corrections Policies November 19, 2015 Wisconsin s overuse of jails and prisons has resulted in outsized costs for state residents. By emphasizing high-cost
More informationINSTITUTE of PUBLIC POLICY
INSTITUTE of PUBLIC POLICY Harry S Truman School of Public Affairs University of Missouri ANALYSIS OF STATE REVENUES AND EXPENDITURES Andrew Wesemann and Brian Dabson Summary This report analyzes state
More informationCalifornia Healthcare Dollars and Politics
California Healthcare Dollars and Politics On health-related bills, how lawmakers vote correlates closely with campaign donations. October 17, 2007 Contact: Dan Newman, Executive Director 510-868-0894
More informationJanuary 17, 2017 Women in State Legislatures 2017
January 17, 2017 in State Legislatures 2017 Kelly Dittmar, Ph.D. In 2017, 1832 women (1107D, 703R, 4I, 4Prg, 1WFP, 13NP) hold seats in state legislatures, comprising 24.8% of the 7383 members; 442 women
More informationCase 1:18-cv UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00117-UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TEVA PHARMACEUTICALS INTERNATIONAL GMBH, CEPHALON, INC., and EAGLE
More informationa rising tide? The changing demographics on our ballots
a rising tide? The changing demographics on our ballots OCTOBER 2018 Against the backdrop of unprecedented political turmoil, we calculated the real state of the union. For more than half a decade, we
More informationDisclosures. State Legislative Compounding Update. States Biennial Sessions Learning Objectives. State Legislative Overview
State Legislative Compounding Update David A. Kosar Consultant NASPA & IACP Disclosures David A. Kosar declare(s) no conflicts of interest, real or apparent, and no financial interests in any company,
More informationBreakdown of the Types of Specific Criminal Convictions Associated with Criminal Aliens Placed in a Non-Custodial Setting in Fiscal Year 2015
Breakdown the Types Specific Criminal Associated with Criminal Placed in a Non-Custodial Setting in Fiscal Year 2015 The following table below provides a breakdown the types specific criminal convictions
More informationCRAIN S CLEVELAND BUSINESS
PAID CIRCULATION CRAIN S CLEVELAND BUSINESS Cleveland, Ohio 44113 FIELD SERVED: CRAIN S CLEVELAND BUSINESS serves the general business information needs of executives, managers and professionals in the
More informationBy 1970 immigrants from the Americas, Africa, and Asia far outnumbered those from Europe. CANADIAN UNITED STATES CUBAN MEXICAN
In Search of the American Dream After World War II, millions of immigrants and citizens sought better lives in the United States. More and more immigrants came from Latin America and Asia. Between 940
More informationSenators of the 111th Congress
Senators of the 111th Congress Begich, Mark - (D - AK) 144 RUSSELL SENATE OFFICE BUILDING WASHINGTON DC 20510 (202) 224-3004 Web Form: begich.senate.gov/contact/contact.cfm Murkowski, Lisa - (R - AK) 709
More informationRepublic Act Generics Act of 1988
Republic Act 6675 - Generics Act of 1988 By rhissa Published: 2006-02-21 16:17 Republic of the Philippines CONGRESS OF THE PHILIPPINES Metro Manila Second Regular Session Begun and held in Metro Manila,
More informationAmerican Nephrology Nurses Association. Weekly Capitol Hill Update Tuesday, March 27, Congressional Schedule
American Nephrology Nurses Association Weekly Capitol Hill Update Tuesday, March 27, 2018 Senate Congressional Schedule House Congress on two-week Easter break; Senate set to return to D.C. week of April
More informationHealth Care Bills Introduced in Congress March 13 to March 17, 2017
Date Bill Number House/Senate Sponsors Bill Title Committee of Jurisdiction HOUSE 3/13 H.R.1519 Rep. Kind (D-WI) To provide for the publication by the Secretary of Health and Human Services of physical
More informationWorkshop #36 The 114th Congress and the DoD Budget. Colonel Randy Toris OUSD Comptroller/BAA 3 June 2016
Workshop #36 The 114th Congress and the DoD Budget Colonel Randy Toris OUSD Comptroller/BAA 3 June 2016 Who ARE you people??? 2 The Overhead View The Congressional environment The current picture Why do
More informationHealth Policy Briefing
Health Policy Briefing November 21, 2016 Congress Moves Forward on Short Term CR Following a meeting between Vice President-Elect Mike Pence and House Republicans last week to discuss the lame duck agenda,
More informationWhat is Next for Health Care Reform?
What is Next for Health Care Reform? Nicole Lamoureux, CEO National Association of Free & Charitable Clinics Presentation Disclaimer The views and opinions expressed in this presentation are for illustrative
More informationCongressional Policy-Making. How does a Bill become a Law?
Congressional Policy-Making How does a Bill become a Law? Recap: Political Competition! Interest group competition! Distributive politics! Collective action and free riding! Useful for understanding which
More informationUniform Wage Garnishment Act
Uniform Wage Garnishment Act Agenda What is it? Why do we need it? Major provisions Enactment 1 Who is the ULC? National Conference of Commissioners for Uniform State Laws Uniform Interstate Family Support
More informationFSC-BENEFITED EXPORTS AND JOBS IN 1999: Estimates for Every Congressional District
FSC-BENEFITED EXPORTS AND JOBS IN 1999: Estimates for Every Congressional District Prepared for National Foreign Trade Council July 2, 2002 National Economic Consulting FSC-BENEFITED EXPORTS AND JOBS IN
More informationThe Youth Vote in 2008 By Emily Hoban Kirby and Kei Kawashima-Ginsberg 1 Updated August 17, 2009
The Youth Vote in 2008 By Emily Hoban Kirby and Kei Kawashima-Ginsberg 1 Updated August 17, 2009 Estimates from the Census Current Population Survey November Supplement suggest that the voter turnout rate
More informationHEALTHCARE PROVIDER LIABILITY IN WEST VIRGINIA UPDATE ON THE LAW
HEALTHCARE PROVIDER LIABILITY IN WEST VIRGINIA UPDATE ON THE LAW 2015-2016 Medical Malpractice Claims in West Virginia The Medical Professional Liability Act (MPLA) West Virginia Code Section 55-7B-1 et
More informationRULE 2.4: LAWYER SERVING
American Bar Association CPR Policy Implementation Committee Variations of the ABA Model Rules of Professional Conduct RULE 2.4: LAWYER SERVING AS THIRD-PARTY NEUTRAL (a) A lawyer serves as a third-party
More informationState Governments Viewed Favorably as Federal Rating Hits New Low
APRIL 15, 2013 State Governments Viewed Favorably as Federal Rating Hits New Low FOR FURTHER INFORMATION CONTACT THE PEW RESEARCH CENTER FOR THE PEOPLE & THE PRESS Michael Dimock Director Carroll Doherty
More informationTEXAS DRUG UTILIZATION REVIEW BOARD
1 OF 7 I) Authority The Texas Medicaid Drug Utilization Review (DUR) Board (Board) is established under the authority of Section 1927(g)(3) of the Social Security Act and Section 531.0736 of the Texas
More informationAdmitting Foreign Trained Lawyers. National Conference of Bar Examiners Washington, D.C., April 15, 2016
Admitting Foreign Trained Lawyers National Conference of Bar Examiners Washington, D.C., April 15, 2016 Professor Laurel S. Terry Carlisle, Pennsylvania LTerry@psu.edu Overview of Remarks Why this issue
More informationSort by: Name State Party. What is a class?
1 of 7 Home > Senators Home Senators of the 111th Congress Sort by: Name State Party What is a class? XML Information about any senator, representative, vice president, or member of the Continental Congress.
More informationAYOTTE SIDED WITH THE KOCH BROTHERS, REPEATEDLY VOTED AGAINST CLOSING TENS OF BILLIONS IN SPECIAL TAX LOOPHOLES FOR BIG OIL COMPANIES
AYOTTE VOTED WITH THE KOCH BROTHERS NEARLY 90% OF THE TIME DURING HER FIRST FOUR YEARS IN OFFICE Ayotte Voted With Americans For Prosperity 89% Of The Time During The 112 th Congress. [AFP Scorecard, Accessed
More informationHealth Policy Briefing
This Week in Congress Health Policy Briefing September 10, 2018 The House of Representatives plans to vote on a package of bills this week that would retroactively lift the Affordable Care Act s (ACA)
More informationHP0557, LD 821, item 2, 124th Maine State Legislature, Amendment C "A", Filing Number H-625, Sponsored by
PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney. Amend the bill by striking out everything
More informationPrevention Of Corruption
Prevention Of Corruption Global Compliance Table Of Contents Standards Application page 6 Purpose page 5 Scope page 6 Bribery/Improper Payments, page 8 Ethical Business Practices, page 8 Unfair Business
More informationUpdate on Federal Issues
Update on Federal Issues HFMA Region 7 Conference September 28, 2018 South Bend, IN Presentation Overview Congressional Action 2018 Election Regulatory Update Working with Congress Fall Preview Unfinished
More informationNow is the time to pay attention
Census & Redistricting : Now is the time to pay attention By Kimball Brace, President Election Data Services, Inc. Definitions Reapportionment Allocation of districts to an area Example: Congressional
More informationSecretary of the Senate Office of Public Records 232 Hart Building Washington, DC PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Clerk of the House of Representatives Legislative Resource Center B-106 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov Secretary of the Senate Office of Public Records 232 Hart
More informationSIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2018 BUDGET SESSION
AN ACT relating to controlled substances; creating an opioid addiction task force; specifying task force duties, membership and staffing; requiring coordination between the advisory council on palliative
More informationCandidate Faces and Election Outcomes: Is the Face-Vote Correlation Caused by Candidate Selection? Corrigendum
Quarterly Journal of Political Science, 2010, 5: 99 105 Corrigendum Candidate Faces and Election Outcomes: Is the Face-Vote Correlation Caused by Candidate Selection? Corrigendum Matthew D. Atkinson, Ryan
More informationBYLAWS OF THE NATIONAL STUDENT SPEECH LANGUAGE HEARING ASSOCIATION
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 BYLAWS OF THE NATIONAL STUDENT SPEECH LANGUAGE HEARING ASSOCIATION ARTICLE I Name Section
More informationInside Washington. Marco
Inside Washington Marco Giamberardino @NECAGovtAffairs Washington Today Washington On It s Knees A Paralyzed Congress: Still Unsure About How to Work with New Administration Criticism Abounds: Media, At
More informationTuesday, February 10, :45 AM Mountain
Tuesday, February 10, 2015 9:45 AM Mountain Protect Rural Health Care! aha.org/ruraladvocacy #RuralHealth Today s Speakers: Sarah Macchiarola, Senior Associate Director, Federal Relations, American Hospital
More informationH. R. ll. To increase competition in the pharmaceutical industry. IN THE HOUSE OF REPRESENTATIVES A BILL
G:\M\\SCHRAD\SCHRAD_00.XML H TH CONGRESS ST SESSION... (Original Signature of Member) H. R. ll To increase competition in the pharmaceutical industry. IN THE HOUSE OF REPRESENTATIVES Mr. SCHRADER introduced
More informationJANUARY FEBRUARY MARCH MAY JUNE APRIL JULY AUGUST SEPTEMBER OCTOBER NOVEMBER DECEMBER S M T W T F S S M T W T S M T W T F S S M T W T F S
JANUARY FEBRUARY MARCH 5 6 7 8 9 0 4 5 6 7 8 9 0 9 0 4 5 9 0 4 4 5 4 5 6 7 8 6 7 8 6 7 8 9 0 9 0 APRIL MAY JUNE S M T W T 4 F 5 S 6 S M T W T F S 4 5 6 7 8 7 8 9 0 4 5 6 7 8 9 0 9 0 4 5 4 5 6 7 8 9 0 4
More informationSeniorSource SENATOR COLLINS WRITES OP-ED ON DRUG PRICING INVESTIGATION
April 2016 SENATOR COLLINS WRITES OP-ED ON DRUG PRICING INVESTIGATION A Newsletter from U.S. Senator Susan Collins Chairman, Senate Special Committee on Aging treatment for their daughter, a cost that
More informationMigrant and Seasonal Head Start. Guadalupe Cuesta Director, National Migrant and Seasonal Head Start Collaboration Office
Migrant and Seasonal Head Start Guadalupe Cuesta Director, National Migrant and Seasonal Head Start Collaboration Office The Migrant Seasonal Head Start (MSHS) program is one of the largest community based
More informationSecond medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines
Question Q238 National Group: Title: Contributors: Reporter within Working Committee: PHILIPPINES Second medical use or indication claims Mr. Alex Ferdinand FIDER Mr. Antonio Ray ORTIGUERA Angara Abello
More informationRULE 3.8(g) AND (h):
American Bar Association CPR Policy Implementation Committee Variations of the ABA Model Rules of Professional Conduct RULE 3.8(g) AND (h): (g) When a prosecutor knows of new, credible and material evidence
More information#36 The 114th Congress and the DoD Budget. Colonel Randy Toris OUSD Comptroller/BAA 29 May 2015
#36 The 114th Congress and the DoD Budget Colonel Randy Toris OUSD Comptroller/BAA 29 May 2015 Kinda like C-SPAN.but not The Congressional environment Politics makes strange bedfellows Why do you care?
More informationHOUSE AMENDMENT Bill No. HB 5511 (2012) Amendment No. CHAMBER ACTION
CHAMBER ACTION Senate House. 1 The Conference Committee on HB 5511 offered the following: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Conference Committee Amendment (with title amendment) Remove everything after
More informationLeadership in the 115 th Congress
Leadership in the 115 th Congress A combination of events will spell changes to the leadership of both parties in both Chambers in the 115 th Congress. In the Senate, the retirement of Democratic Leader
More informationHealth Policy Briefing
Negotiations Begin on Government Funding Health Policy Briefing February 4, 2019 Lawmakers on Capitol Hill have begun negotiations on a legislative option to avoid another partial government shutdown.
More informationIC Chapter 19. Drugs: Indiana Legend Drug Act
IC 16-42-19 Chapter 19. Drugs: Indiana Legend Drug Act IC 16-42-19-1 Intent of chapter Sec. 1. This chapter is intended to supplement IC 16-42-1 through IC 16-42-4. IC 16-42-19-2 "Drug" Sec. 2. As used
More informationCurrent WIC Policy Issues & Analysis
Current WIC Policy Issues & Analysis Ali Hard, Senior Associate, Federal Government Affairs Brian Dittmeier, State Government Affairs Counsel National WIC Association March 4, 2018 2018 Washington Leadership
More informationSenators of the 110th Congress
Find Your Senators Search Home > Senators Home Senators of the 110th Congress Sort by: Name State Party Choose a State Choose a Senator Choose a Class Photos and contact information for the new senators
More informationDraft Senate Health Bill Finally Revealed Vote Could Take Place as Early Next Week
Draft Senate Health Bill Finally Revealed Vote Could Take Place as Early Next Week Introduction On June 22, 2017, Republican Senators released a discussion draft of the Better Care Reconciliation Act (BCRA).
More informationAmbassador Briefing. July 8, 2015
Ambassador Briefing July 8, 2015 Welcome! Laura Keivel Manager of Grassroots Advocacy Thank you for joining the call and participating in the Ambassador Program! Agenda State and Federal Updates JA Conference
More information2016 NATIONAL CONVENTION
Delegate Allocations and Region Formation 2016 NATIONAL CONVENTION ROSEN CENTRE, ORLANDO, FL FRIDAY, MAY 27 MONDAY, MAY 30 Written and Prepared By Alicia Mattson Secretary, Libertarian National Committee
More informationBallot Questions in Michigan. Selma Tucker and Ken Sikkema
Ballot Questions in Michigan Selma Tucker and Ken Sikkema PUBLIC SECTOR PUBLIC CONSULTANTS SECTOR CONSULTANTS @PSCMICHIGAN @PSCMICHIGAN PUBLICSECTORCONSULTANTS.COM Presentation Overview History of ballot
More information